AKI group (n =52) | Non-AKI group (n =79) | P | |
---|---|---|---|
Preoperative (baseline) | |||
Male (%) | 35 (67.3) | 47 (59.5) | 0.461 |
Age, years | 59.06 ± 10.39 | 55.43 ± 13.47 | 0.085 |
Hypertension (%) | 18 (34.6) | 26 (32.9) | 0.852 |
Diabetes (%) | 15 (28.8) | 17 (21.5) | 0.407 |
Heart disease (%)1) (EF < 50% or coronary artery disease) | 2 (3.8) | 2 (2.5) | 0.649 |
Baseline eGFR, ml/min/1.73 m2 | 94.94 ± 25.41 | 95.46 ± 20.68 | 0.898 |
MELD-Na score | 11.46 ± 7.06 | 8.05 ± 3.11 | 0.002 |
Child-Pugh score | 6.21 ± 2.18 | 5.29 ± 1.04 | 0.006 |
ICG-R15,%2) | 12.79 ± 9.36 | 12.22 ± 5.96 | 0.743 |
Mean arterial pressure, mmHg | 86.38 ± 10.19 | 88.00 ± 9.65 | 0.359 |
Total bilirubin, mg/dL | 2.27 ± 4.25 | 0.88 ± 1.80 | 0.030 |
Serum Na, mmol/L | 138.33 ± 6.01 | 140.22 ± 2.16 | 0.034 |
Prothrombin time, INR | 1.23 ± 0.43 | 1.048 ± 0.23 | 0.006 |
Albumin, g/dL | 3.70 ± 0.58 | 3.97 ± 0.55 | 0.009 |
ALT, IU/L | 25.85 ± 15.10 | 28.47 ± 40.10 | 0.653 |
AST, IU/L | 35.15 ± 16.22 | 30.28 ± 25.18 | 0.218 |
CRP, mg/L | 6.56 ± 16.40 | 10.33 ± 35.99 | 0.503 |
Reason for operation (%) | <0.001 | ||
Hepatocellular carcinoma | 29 (55.8) | 25 (31.6) | |
Liver metastasis | 3 (5.8) | 24 (30.4) | |
Cholangiocarcinoma | 9 (17.3) | 10 (12.7) | |
Liver cirrhosis | 7 (13.5) | 2 (2.5) | |
Others | 4 (7.7) | 18 (22.8) |